Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Clinical trial NCT00886496 · WITHDRAWN

Trial details

NCT number: NCT00886496
Sponsor: Enzon Pharmaceuticals, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Fever, Sweats, and Hot Flashes Infection Leukemia Lymphoma Myelodysplastic Syndromes Neutropenia Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2006-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.